| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | 0.0099 | 0.8 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | 0.0091 | 0.8 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | -0.0097 | 0.8 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | -0.0095 | 0.8 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0097 | 0.8 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | -0.014 | 0.8 |